When patients are seriously harmed by defective drugs, they have a right to be compensated for this harm. Those who have been victimized by such products also have the right to effective legal representation.
Cleveland, Ohio (PRWEB) September 20, 2011
The FDA has issued a warning for the diabetes drug Actos (pioglitazone) due to the increased risk of bladder cancer among those who have taken the drug for more than one year(2). An epidemiological study in France has also linked Actos to an increased risk of bladder cancer(1). The Spangenberg Law Firm is investigating Actos bladder cancer claims on behalf of potential clients today.
Currently, there are at least a dozen Actos lawsuits pending(3). Plaintiffs Glen and Nina Weant have filed a motion asking the U.S. Judicial Panel on Multidistrict Litigation to consolidate all federal Actos lawsuits in the U.S. District Court for the Southern District of Illinois.(4) According to the filing, there are at least 11 lawsuits pending in 8 different federal district courts throughout the United States involving individuals who developed bladder cancer after Actos use.
The FDA is advising those who currently have bladder cancer, or a history of bladder cancer not to start a drug regimen that includes Actos.
Actos is a part of the drug class known as thiazolidinedione, which is used in patients with type 2 diabetes in order to help control blood sugar levels by increasing the body’s sensitivity to insulin. The diabetes drug was developed, manufactured and sold by Takeda Pharmaceuticals. Actos is marketed under the following names: Actos; Actoplus Met; Duetact.
Do not hesitate to contact an Actos bladder cancer lawyer as soon as possible if you think you may have a claim. Every state has a statute of limitations period in which one is eligible to file a lawsuit, and if this date is surpassed, a claim may not be able to be filed.
An experienced Actos lawyer can help determine whether you have a case, the statute of limitations time left, and answer any question one might have about the process of filing an Actos lawsuit. We work on a contingency fee basis, meaning there is no cost to you to pursue a claim. Instead, our fee and the case expenses only come out of a recovery at the conclusion of the case, and there is never an out-of-pocket cost to you.
1) Stephensen, Joan “Diabetes Drug May Be Associated With Increase in Risk of Bladder Cancer” http://jama.ama-assn.org/content/306/2/143.short
2) Fiore, Kristina “FDA Warns of Bladder Cancer Risk With Actos” http://abcnews.go.com/Health/DiabetesTreatment/fda-warns-bladder-cancer-risk-actos/story?id=13850066
3) See In re: Actos Products Liability Litigation, MDL No. 2299 (filed 8-31-2011)